|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02615 BIOKIN
Nominal 
() | 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Turnover | 170,409 | -96.931% | 5,821,050 | 560,416 | 701,833 |
| Cost of Sales | (102,882) | -16.824% | (290,827) | (253,401) | (246,844) |
| Gross Profit | 67,527 | -98.756% | 5,530,223 | 307,015 | 454,989 |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | 2,611 | 169.731% | (2,191) | 6,442 | (7,686) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (1,127,910) | -- | 3,978,154 | (769,013) | (289,074) | |
| Taxation | 9,958 | -- | (270,649) | (11,486) | 6,695 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (1,117,952) | -- | 3,707,505 | (780,499) | (282,379) | |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (81,412) | 19.219% | (163,564) | 18,976 | 21,714 |
| Depreciation & Amortisation | 40,023 | 36.565% | 64,240 | 45,773 | 42,811 |
| Directors' Emoluments | 7,347 | 28.534% | 13,177 | 6,920 | 4,988 |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | -279.000 | -- | 925.000 | -195.000 | -78.000 |
| DPS (cts) | -- | -- | -- | -- | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 9.581 | (1.541) | (0.710) |
| NBV per share ($) | -- | -- | -- | -- | -- |
| Remarks: | Real time quote last updated: 20/11/2025 10:22 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -1,117,952 |
| %Change | -- |
| EPS / (LPS) | RMB -2.790 |
| NBV Per Share (¥) | RMB -- |